AMERICAN MOLECULES LLC – Trademark Portfolio

Entity Type: 16

AMERICAN MOLECULES LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include SCALEFLUSH. The owner is based in SUGAR LAND, TX.

6903 GOSSAMER LN

SUGAR LAND, TX 77479

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AMERICAN MOLECULES LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does AMERICAN MOLECULES LLC have?

AMERICAN MOLECULES LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending.

What trademark classes does AMERICAN MOLECULES LLC file in?

AMERICAN MOLECULES LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are AMERICAN MOLECULES LLC's most well-known trademarks?

AMERICAN MOLECULES LLC's registered trademark portfolio includes well-known marks such as SCALEFLUSH. These are among 1 currently registered trademark in the portfolio.

What is AMERICAN MOLECULES LLC's trademark registration success rate?

AMERICAN MOLECULES LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.